Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
Antonella d’Arminio Monforte(University of Milan), Carlo Torti(Magna Graecia University), Miriam Lichtner(Sapienza University of Rome), Francesca Bai(AOL (United States)), Spinello Antinori(University of Milan), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), C Mussini(Azienda Ospedaliero-Universitaria di Modena), Loredana Sarmati(University of Rome Tor Vergata), Alessandro Tavelli, Francesco Maria Fusco(Ospedale Santa Maria Annunziata), Adriano Lazzarin(Vita-Salute San Raffaele University), Roberto Cauda(Università Cattolica del Sacro Cuore), Andrea Antinori(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Eugenia Quirós-Roldán(Karolinska Institutet), Antonella Cingolani(Agostino Gemelli University Polyclinic), Pierluigi Viale(Azienda USL di Bologna), Alessandro Cozzi‐Lepri(University College London), Giancarlo Orofino(Ospedale Amedeo di Savoia), Antonella Castagna(Vita-Salute San Raffaele University), Barbara Suligoi, Alessandra Vergori(University of Rome Tor Vergata), R Iardino, Andrea Gori(University of Milan), Silvia Nozza(IRCCS Ospedale San Raffaele), Francesca Ceccherini‐Silberstein(University of Cologne), Alessandra Bandera(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giulia Marchetti(AOL (United States)), Enrico Girardi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Cristina Mussini(University of Modena and Reggio Emilia), Stefania Piconi(Alessandro Manzoni Hospital), Sergio Lo Caputo(Ospedale Santa Maria Annunziata), Franco Maggiolo(Ospedale Papa Giovanni XXIII), Carlo Federico Perno(Centre International De Reference Chantal Biya), Eugenio Quiros Roldan(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Giovanni Di Perri(University of Turin), F von Schloesser, G Marchetti(AOL (United States)), Antonio Di Biagio
Cited by 9
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Female gender is associated with long COVID syndrome: a prospective cohort study
|Clinical Microbiology and Infection|2021|656
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653